A catabolite of uracil
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Product Categories

Research Area

5,6-Dihydrouracil

Item No. 36438

Technical Information
Formal Name
dihydro-2,4(1H,3H)-pyrimidinedione
CAS Number
504-07-4
Synonyms
  • NSC 11867
Molecular Formula
C4H6N2O2
Formula Weight
Purity
≥98%
A solid
DMF: insolDMSO: 1 mg/mlEthanol: insolPBS (pH 7.2): 1 mg/ml
SMILES
O=C1NC(CCN1)=O
InChi Code
InChI=1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)
InChi Key
OIVLITBTBDPEFK-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    5,6-Dihydrouracil is a catabolite of uracil (Item No. 26088).1 It is formed from uracil by dihydropyrimidine dehydrogenase. The plasma ratio of 5,6-dihydrouracil to uracil has been used as a phenotypic marker of dihydropyrimidine dehydrogenase activity.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Büchel, B., Rhyn, P., Schürch, S., et alLC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients. Biomed. Chromatogr. 27(1), 7-16 (2013).

    2. Chavani, O., Jensen, B.P., Strother, R.M., et alDevelopment, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, α-fluoro-β-ureidopropionic acid and α-fluoro-β-alanine in human plasma. J. Pharm. Biomed. Anal. 142, 125-135 (2017).